Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis
Authors
Keywords
PI3K/Akt, Hypoxia, HIF-1α, Apoptosis, Rhabdomyosarcoma, Ewing’s sarcoma
Journal
Cancer Cell International
Volume 13, Issue 1, Pages 36
Publisher
Springer Nature
Online
2013-04-17
DOI
10.1186/1475-2867-13-36
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Aberrant PI3K/Akt Activation by PI103 Restores Sensitivity to TRAIL-Induced Apoptosis in Neuroblastoma
- (2011) D. Opel et al. CLINICAL CANCER RESEARCH
- Expression of therapeutic targets in Ewing sarcoma family tumors
- (2011) Atif A. Ahmed et al. HUMAN PATHOLOGY
- PI3K: A potential therapeutic target for cancer
- (2011) Yingwei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1α (HIF-1α) Pathways
- (2011) Natalie Burrows et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ewing's sarcoma
- (2010) A. O. Karosas AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway
- (2010) Pinelopi Argyriou et al. ANNALS OF HEMATOLOGY
- P70S6K 1 regulation of angiogenesis through VEGF and HIF-1α expression
- (2010) Chuan-Xiu Bian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targets for cancer therapy in childhood sarcomas
- (2010) Marco Wachtel et al. CANCER TREATMENT REVIEWS
- Emerging Metabolic Targets in Cancer Therapy
- (2010) Yuhua Zhao Frontiers in Bioscience-Landmark
- PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
- (2010) A Bender et al. ONCOGENE
- PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines
- (2009) Norazizah Shafee et al. CANCER LETTERS
- The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
- (2009) S. Fulda CURRENT CANCER DRUG TARGETS
- Oxygen homeostasis
- (2009) Gregg L. Semenza Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- and Drug-Induced Apoptosis
- (2008) D. Opel et al. CANCER RESEARCH
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Notch1 is an effector of Akt and hypoxia in melanoma development
- (2008) Barbara Bedogni et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now